BDTX

Black Diamond Therapeutics I

-$15.2M

Net Activity

Institutions Holding

100

Popularity Rank

#4442

Avg Weight

0.01%

Total Value

$77.6M

Ownership Trend

100 institutions currently hold BDTX, with 49 net buyers and 55 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

55

Net Buying Institutions

49

Key Holders

View all 100 holding institutions

Quarterly Activity

Recent Activity

+$33.2M

Total Buy Value

$51.4M

Total Sell Value

New buy19
Trim33
Add30
Sold out22

49

Net Buyers

55

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

1

Active 5%+ Holders

Data as of 2026-07-08
Reporting PersonTypeFiling Date% of Class
T. Rowe Price Investment Management, Inc.13G/A2026-07-087.0%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BLACK DIAMOND THERAPEUTICS I (BDTX)?
Major stakeholders currently include T. Rowe Price Investment Management, Inc. ($22.5M), NEA Management Company, LLC ($9.5M), Acadian Asset Management LLC ($5.0M). Based on the latest 13F filings, there are a total of 100 tracked investment funds and institutions maintaining positions in BDTX.
What is the overall institutional sentiment toward BDTX recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $15.2M, driven by 49 managers accumulating shares while 55 reduced their exposure.
Which institutions have been selling or reducing their BDTX positions?
In the latest period, 33 funds trimmed their holdings, and 22 managers completely exited their positions. The aggregate reported sell value was $51.4M.
Are there any notable investors adding BDTX to their portfolios?
Yes, buying activity remains notable. 19 institutions opened new positions in {ticker}, and 30 existing holders added to their shares. The total reported buy value for the quarter amounted to $33.2M.

Related Stocks